Dr. Rebecca Wong, M.D.
Claim this profileUniversity Health Network - Princess Margaret Cancer Centre
Affiliated Hospitals
University Health Network, Princess Margaret Hospital
Clinical Trials Rebecca Wong, M.D. is currently running
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting
2 awards
Phase 3
12 criteria
Surgery Alone vs Surgery + Radiation
for Bone Cancer
Bone is a common site of metastasis for a range of malignancies. Bone metastases have the potential to cause significant morbidity including pain, impairment of ambulation and reduced functional independence. Previous research has shown that pathological fractures are observed in 9 to 29 percent of patients with long bone metastases, and a high proportion of these require surgical intervention to relieve pain and restore function. The goal of this study is to describe the clinical outcomes of patients with femoral metastases at high risk of pathological fracture. Patients referred for treatment of femoral metastases at high risk of fracture will be followed prospectively after undergoing with surgery (± post-operative radiotherapy), or radiotherapy alone. Patient and disease characteristics, ambulatory status and limb function will be documented before treatment. These Clinical outcomes of participants in each treatment group will be measured 6 weeks after treatment, and 3- and 6 months after enrolment, with particular reference to patient-reported outcomes relating to pain, ambulatory status, limb function and quality of life.
Recruiting
1 award
N/A
5 criteria
More about Rebecca Wong, M.D.
Clinical Trial Related
3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Rebecca Wong, M.D. has experience with
- Combined Surgery And Radiation Therapy
- Surgery Alone
- RYZ101
- Lutetium-177 Octreotate
- CAM-H2
Breakdown of trials Rebecca Wong, M.D. has run
Neuroendocrine Tumors
Carcinoid Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca Wong, M.D. specialize in?
Rebecca Wong, M.D. focuses on Neuroendocrine Tumors and Osteoporosis. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are undergoing treatment.
Is Rebecca Wong, M.D. currently recruiting for clinical trials?
Yes, Rebecca Wong, M.D. is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Rebecca Wong, M.D. has studied deeply?
Yes, Rebecca Wong, M.D. has studied treatments such as Combined Surgery and Radiation therapy, Surgery Alone, RYZ101.
What is the best way to schedule an appointment with Rebecca Wong, M.D.?
Apply for one of the trials that Rebecca Wong, M.D. is conducting.
What is the office address of Rebecca Wong, M.D.?
The office of Rebecca Wong, M.D. is located at: University Health Network, Princess Margaret Hospital, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the University Health Network, Princess Margaret Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.